(NASDAQ: RXST) Rxsight's forecast annual revenue growth rate of 2.87% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.46%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.62%.
Rxsight's revenue in 2025 is $148,310,000.On average, 5 Wall Street analysts forecast RXST's revenue for 2025 to be $5,145,698,356, with the lowest RXST revenue forecast at $5,087,750,021, and the highest RXST revenue forecast at $5,262,489,040. On average, 6 Wall Street analysts forecast RXST's revenue for 2026 to be $5,863,428,715, with the lowest RXST revenue forecast at $4,986,157,569, and the highest RXST revenue forecast at $7,678,357,560.
In 2027, RXST is forecast to generate $6,557,101,980 in revenue, with the lowest revenue forecast at $5,445,355,454 and the highest revenue forecast at $8,549,614,433.